Elevance Health Pre-Tax Profit Margin 2012-2026 | ELV
Current and historical pre-tax profit margin for Elevance Health (ELV) from 2012 to 2026. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Elevance Health pre-tax profit margin for the three months ending June 30, 2026 was .
| Elevance Health Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2026-06-30 | $201.11B | $5.86B | 2.91% |
| 2026-03-31 | $200.42B | $6.22B | 3.10% |
| 2025-12-31 | $199.13B | $6.71B | 3.37% |
| 2025-09-30 | $194.82B | $7.10B | 3.64% |
| 2025-06-30 | $189.22B | $7.07B | 3.74% |
| 2025-03-31 | $183.33B | $7.76B | 4.23% |
| 2024-12-31 | $177.01B | $7.90B | 4.47% |
| 2024-09-30 | $174.22B | $8.30B | 4.76% |
| 2024-06-30 | $171.96B | $8.58B | 4.99% |
| 2024-03-31 | $171.75B | $8.04B | 4.68% |
| 2023-12-31 | $171.34B | $7.72B | 4.50% |
| 2023-09-30 | $168.62B | $7.76B | 4.60% |
| 2023-06-30 | $165.71B | $8.23B | 4.97% |
| 2023-03-31 | $160.67B | $7.91B | 4.92% |
| 2022-12-31 | $156.60B | $7.60B | 4.85% |
| 2022-09-30 | $153.25B | $8.03B | 5.24% |
| 2022-06-30 | $149.13B | $7.89B | 5.29% |
| 2022-03-31 | $144.35B | $8.13B | 5.63% |
| 2021-12-31 | $138.64B | $8.00B | 5.77% |
| 2021-09-30 | $133.88B | $7.14B | 5.33% |
| 2021-06-30 | $129.22B | $5.53B | 4.28% |
| 2021-03-31 | $124.63B | $6.33B | 5.07% |
| 2020-12-31 | $121.87B | $6.24B | 5.12% |
| 2020-09-30 | $117.45B | $6.73B | 5.73% |
| 2020-06-30 | $112.97B | $7.83B | 6.93% |
| 2020-03-31 | $109.17B | $6.13B | 5.61% |
| 2019-12-31 | $104.21B | $5.99B | 5.74% |
| 2019-09-30 | $100.18B | $5.43B | 5.42% |
| 2019-06-30 | $96.76B | $5.18B | 5.36% |
| 2019-03-31 | $94.23B | $5.23B | 5.55% |
| 2018-12-31 | $92.11B | $5.07B | 5.50% |
| 2018-09-30 | $91.41B | $4.65B | 5.09% |
| 2018-06-30 | $90.59B | $4.53B | 5.00% |
| 2018-03-31 | $90.05B | $4.23B | 4.70% |
| 2017-12-31 | $90.04B | $3.96B | 4.40% |
| 2017-09-30 | $89.07B | $4.50B | 5.05% |
| 2017-06-30 | $88.05B | $4.52B | 5.13% |
| 2017-03-31 | $87.10B | $4.76B | 5.46% |
| 2016-12-31 | $84.86B | $4.56B | 5.37% |
| 2016-09-30 | $83.34B | $4.27B | 5.12% |
| 2016-06-30 | $81.84B | $4.26B | 5.21% |
| 2016-03-31 | $80.40B | $4.37B | 5.44% |
| 2015-12-31 | $79.16B | $4.63B | 5.85% |
| 2015-09-30 | $77.95B | $5.14B | 6.60% |
| 2015-06-30 | $76.61B | $5.10B | 6.66% |
| 2015-03-31 | $75.07B | $4.81B | 6.40% |
| 2014-12-31 | $73.87B | $4.37B | 5.91% |
| 2014-09-30 | $72.79B | $3.95B | 5.43% |
| 2014-06-30 | $72.09B | $3.74B | 5.19% |
| 2014-03-31 | $71.31B | $3.69B | 5.17% |
| 2013-12-31 | $71.02B | $3.84B | 5.41% |
| 2013-09-30 | $68.44B | $3.85B | 5.62% |
| 2013-06-30 | $65.94B | $3.99B | 6.05% |
| 2013-03-31 | $63.66B | $3.83B | 6.02% |
| 2012-12-31 | $61.50B | $3.86B | 6.28% |
| 2012-09-30 | $61.49B | $3.86B | 6.28% |
| 2012-06-30 | $61.54B | $3.88B | 6.31% |
| 2012-03-31 | $61.23B | $3.84B | 6.27% |
| 2011-12-31 | $60.71B | $3.96B | 6.52% |
| 2011-09-30 | $60.02B | $4.23B | 7.05% |
| 2011-06-30 | $59.19B | $4.32B | 7.30% |
| 2011-03-31 | $58.52B | $4.45B | 7.60% |
| 2010-12-31 | $58.70B | $4.35B | 7.42% |
| 2010-09-30 | $63.03B | $7.94B | 12.60% |
| 2010-06-30 | $63.89B | $7.92B | 12.40% |
| 2010-03-31 | $64.87B | $7.85B | 12.09% |
| 2009-12-31 | $64.94B | $7.40B | 11.40% |
| 2009-09-30 | $61.05B | $3.57B | 5.85% |
| 2009-06-30 | $60.59B | $3.00B | 4.96% |
| 2009-03-31 | $60.84B | $3.14B | 5.16% |
| 2008-12-31 | $61.25B | $3.12B | 5.10% |
| 2008-09-30 | $61.75B | $3.94B | 6.38% |
| 2008-06-30 | $62.03B | $4.76B | 7.67% |
| 2008-03-31 | $61.63B | $4.89B | 7.93% |
| 2007-12-31 | $61.17B | $5.26B | 8.59% |
| 2007-09-30 | $60.20B | $5.22B | 8.67% |
| 2007-06-30 | $59.40B | $5.10B | 8.59% |
| 2007-03-31 | $58.31B | $4.99B | 8.55% |
| 2006-12-31 | $57.06B | $4.92B | 8.61% |
| 2006-09-30 | $53.82B | $4.67B | 8.68% |
| 2006-06-30 | $50.53B | $4.44B | 8.79% |
| 2006-03-31 | $47.51B | $4.13B | 8.70% |
| 2005-12-31 | $44.61B | $3.89B | 8.72% |
| 2005-09-30 | $39.97B | $3.17B | 7.92% |
| 2005-06-30 | $33.62B | $2.52B | 7.48% |
| 2005-03-31 | $27.08B | $1.98B | 7.32% |
| 2004-12-31 | $20.71B | $1.44B | 6.97% |
| 2004-09-30 | $18.29B | $1.45B | 7.91% |
| 2004-06-30 | $17.75B | $1.39B | 7.80% |
| 2004-03-31 | $17.26B | $1.30B | 7.54% |
| 2003-12-31 | $16.78B | $1.21B | 7.23% |
| 2003-09-30 | $16.48B | $1.16B | 7.02% |
| 2003-06-30 | $15.79B | $1.08B | 6.81% |
| 2003-03-31 | $14.58B | $0.96B | 6.55% |
| 2002-12-31 | $13.29B | $0.80B | 6.03% |
| 2002-09-30 | $11.95B | $0.68B | 5.66% |
| 2002-06-30 | $11.04B | $0.62B | 5.65% |
| 2002-03-31 | $10.70B | $0.57B | 5.33% |
| 2001-12-31 | $10.45B | $0.52B | 5.02% |
| 2001-09-30 | $10.10B | $0.48B | 4.72% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $89.122B | $199.125B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.899B | 26.08 |
| CVS Health (CVS) | United States | $113.624B | 11.33 |
| HCA Healthcare (HCA) | United States | $92.600B | 14.40 |
| Cencora (COR) | United States | $58.924B | 18.00 |
| Natera (NTRA) | United States | $53.245B | 0.00 |
| Labcorp Holdings (LH) | United States | $26.010B | 18.34 |
| Viatris (VTRS) | United States | $19.469B | 6.73 |
| Medpace Holdings (MEDP) | United States | $17.091B | 35.89 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.888B | 0.00 |
| DiDi Global (DIDIY) | China | $16.776B | 184.00 |
| Revvity (RVTY) | United States | $16.007B | 26.81 |
| Solventum (SOLV) | United States | $15.123B | 12.51 |
| Charles River Laboratories (CRL) | United States | $13.274B | 28.09 |
| ICON (ICLR) | Ireland | $12.565B | 17.08 |
| BrightSpring Health Services (BTSG) | United States | $11.235B | 38.63 |
| Avantor (AVTR) | United States | $10.497B | 18.93 |
| BioMerieux (BMXMF) | France | $9.856B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $8.472B | 83.28 |
| HealthEquity (HQY) | United States | $7.870B | 25.64 |
| Sonic Healthcare (SKHHY) | Australia | $6.732B | 0.00 |
| PACS (PACS) | United States | $6.666B | 22.40 |
| GETINGE (GNGBY) | Sweden | $6.516B | 18.40 |
| CochLear (CHEOY) | Australia | $6.200B | 0.00 |
| MiniMed (MMED) | United States | $6.131B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.021B | 22.77 |
| Sotera Health (SHC) | United States | $5.345B | 22.03 |
| Concentras Parent (CON) | United States | $4.523B | 22.31 |
| Organon (OGN) | United States | $3.593B | 4.56 |
| GeneDx Holdings (WGS) | United States | $3.015B | 280.83 |
| CareDx (CDNA) | United States | $2.785B | 316.65 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.107B | 12.35 |
| COMPASS Pathways (CMPS) | United Kingdom | $2.103B | 0.00 |
| Progyny (PGNY) | United States | $2.082B | 29.49 |
| Establishment Labs Holdings (ESTA) | United States | $2.065B | 0.00 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $2.011B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.839B | 0.00 |
| Freenome (FRNM) | United States | $1.838B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.735B | 66.25 |
| Alignment Healthcare (ALHC) | United States | $1.732B | 43.95 |
| Agilon Health (AGL) | United States | $1.497B | 0.00 |
| InnovAge Holding (INNV) | United States | $1.490B | 0.00 |
| Ardent Health (ARDT) | United States | $1.478B | 8.45 |
| Nutex Health (NUTX) | United States | $1.430B | 8.20 |
| Omada Health (OMDA) | United States | $1.251B | 255.38 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.158B | 22.53 |
| Teladoc Health (TDOC) | United States | $1.145B | 0.00 |
| CryoPort (CYRX) | United States | $0.862B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| GMR Solutions (GMRS) | United States | $0.677B | 0.00 |
| Forward Industries (FWDI) | United States | $0.569B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| SBC Medicals (SBC) | United States | $0.489B | 10.11 |
| Strata Critical Medical (SRTA) | United States | $0.472B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.378B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.377B | 5.48 |
| Biodesix (BDSX) | United States | $0.308B | 0.00 |
| Embecta (EMBC) | United States | $0.300B | 2.59 |
| So-Young (SY) | China | $0.279B | 0.00 |
| LifeMD (LFMD) | United States | $0.155B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.101B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.097B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.088B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.082B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.073B | 8.67 |
| Tevogen (TVGN) | United States | $0.051B | 0.00 |
| DocGo (DCGO) | United States | $0.036B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.016B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.013B | 0.00 |
| Ainos (AIMD) | United States | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.007B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |